About us
The research group behind BREBAD
The study is run by a small team at AmsterdamUMC, in collaboration with Diabeter. You deal with the same people throughout, with no rotating faces.
Prof. Max Nieuwdorp
Internist-endocrinologist specialising in vascular medicine, and head of the department of vascular medicine at AmsterdamUMC. He has spent years studying how gut bacteria influence metabolism and the immune system, and how that can be used to slow diseases such as type 1 diabetes. He holds overall responsibility for the BREBAD study.
Dr Elena Rampanelli
Immunologist at AmsterdamUMC. She studies how signalling molecules from the gut microbiome steer the immune response against beta cells. She leads the immunological part of the study and the laboratory work that preceded it.
Dr Nalini Radhakishun
Internist-endocrinologist and medical manager at Diabeter Centrum Amsterdam. She is involved in the BREBAD study for the clinical perspective and for recruitment.
Jordi Dengerink
MD-PhD candidate. He runs the study day to day: he handles screening, sees you at every visit, and is the person who emails or calls you. All questions about taking part reach him.
Independent advice
Someone who is not involved in the study
Every medical research study in the Netherlands has an independent physician: someone who knows the study but has no role in it, and therefore no stake in your decision. For BREBAD that is Dr Cohn.
You can approach him for a second opinion about taking part, or if there is something you would rather not discuss with the research team. His contact details are in the participant information you receive.
Dr Cohn
Not involved in running the study
Collaboration and funding
Who stands behind the study
- AmsterdamUMC: sponsor and site; visits take place at the Clinical Trial Unit
- Diabeter: national treatment centre for type 1 diabetes, partner in recruitment and care
- BreakthroughT1D: international non-profit for type 1 diabetes research, funder of the study
None of the researchers has a financial interest in the outcome. The funder has no influence over the analysis or the publication of results.
More about the teams
Participating centres
Hospitals helping with recruitment
At these hospitals the BREBAD study is known and patients are told about it. The study visits themselves take place at the Clinical Trial Unit at AmsterdamUMC; your travel costs are reimbursed.
Interested?
Check in one minute whether you can take part
Three short questions, no personal details needed. Not sure? Just send an email. You are not committing to anything.